FDA Investigator Nicole C Victoria, PhD

Nicole C Victoria, PhD has inspections in 4 countries as of 01 Aug 2023. Nicole C Victoria, PhD has collaborated with a combined 2138 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Colombia, Canada, Brazil
A Williams, Aimee J Edwin, Alison A Nicoli, Alison A Stone, Anders W Evenson, Annabelle Crusan, D,VM, Anthony J Ladner, April L Brown, April L Young, Barbara D Wright, Benjamin W Anderson, Billi Jom Johnson, Carl A Huffman, III, Charles R Cote, RIC, Christina A Miller, Christina L Bigham, Corey K Reno, Corrine M Carter, Courtney R Ingalsbe, Courtney R Tiegs, Cynthia F Kleppinger, MD, Dacia E Quick, Darlene L Krieger, Darren D Holaday, David B Wieneke, Debra L Boyd Seale, Demetria L Lueneburg, Denise L Burosh, Douglas W Atkins, Dr. Mark J Seaton, PhD, Elizabeth E Hart (ASCP), MT, Eric S Myskowski, Erin M Mcdowell, Gregory R Brinsley, Gregory S Larson, Gregory W Smith, Harperd, Howard A Burmester, Hugh M Mcclure, II, Ifueko Osemwota, Ivan E Reyes, Jacob W Reynolds, James A Beaulieu, James W Plucinski, Jane E Nelson, Jay V Jariwala, Jeanne J Thai, Jeffry A Bernhardt, Jennifer Al Vollon, Jennifer Alongie Vollom, Jennifer C Adams, Jennifer C Johnson, Jennifer S Ness, Jessica L Johnson, Jocelyn M Muggli, Joel D Hustedt, John E Emmert, John P Hermann, Joseph M Edwin, Justin A Boyd, Karen M Labounty, Kathleen R Jones, PhD, Kathleen S Tormey, Kellie L Thommes, RN, Kellie L Westerbuhr, Kevin A Swiss, PhD, Kevin P Regan, Kimberly Lewandowski Walker, Kristy E Zuroski, Kujtim Sadiku, Lakecha N Lewis, Larry K Austin, Linda Galindo, Lisa Hayka, Lori P Peters, M Edith Snyder, Mada A Tautges, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Matthew B Casale, Melissa D Kalik, Melissa I Michurski, Michele Perry Williams, Michelle J Glembin, Miriam M Ngundi, Msdap Gonzlezk, Natalie A Mickelsen, DVM, Natalie Mickelsen, DVM, Norman Wong, Peter R Lenahan, Rafael Padilla, Ralph Jerndal, Rhonda L Mecl, Roberta W Cunningham, Ronald R Ruff, Ross J Grigsby, Sandra A Hughes, Sandra Sejdinovic, Scott A Golladay, Scott B Laufenberg, Sharon K Thoma, PharmD, Sharon L Matson, Sheri S Oliver, Soyinka S Eneng, Susan A Atcher, Susan D Yuscius, Susan M Atcher, Susan M Matthias, Tara C Singh, Terrance L Scheiber, Timothy G Philips, Timothy R Marrs, Tong Zhou, Tony T Yang, Traci C Kelm, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD

Nicole C Victoria, PhD's Documents

Publish Date Document Type Title
September, 2019 FDA 483 Response WuXi AppTec Inc - Form 483R, 2019-09-30
July, 2018 FDA 483 Rebiotix, Inc. - Form 483, 2018-07-09
October, 2018 EIR Experimur, A Frontage Company - EIR, 2018-10-26
November, 2017 FDA 483 Namsa - Form 483, 2017-11-17
April, 2018 EIR American Preclinical Services - EIR, 2018-04-13
September, 2019 FDA 483 WuXi AppTec Inc - Form 483, 2019-09-10
March, 2019 EIR Animesh Pardanani - EIR, 2019-03-08
April, 2016 EIR Brian E. Driver, MD, Sponsor/Investigator - EIR, 2016-04-22
January, 2020 FDA 483 Children's Healthcare IRB #1 - Form 483, 2020-01-31
September, 2017 FDA 483 Boston Scientific Corporation - Form 483, 2017-09-22
December, 2019 FDA 483 Mainstay Medical Limited US, Inc. - Form 483, 2019-12-20
May, 2018 FDA 483 NAMSA - Form 483, 2018-05-18
July, 2021 FDA 483 Geneva Laboratories, Inc. - Form 483, 2021-07-23
November, 2021 FDA 483 Boston Scientific Corporation - Form 483, 2021-11-18
February, 2018 FDA 483 Melissa Geller - Form 483, 2018-02-02
April, 2016 FDA 483 Response Brian E. Driver, MD, Sponsor/Investigator - Form 483R, 2016-05-06
April, 2016 FDA 483 Brian E. Driver, MD, Sponsor/Investigator - Form 483, 2016-04-22
April, 2018 FDA 483 American Preclinical Services - Form 483, 2018-05-01
September, 2021 FDA 483 Namsa - Form 483, 2021-09-21
August, 2018 FDA 483 Inotiv, Inc - Form 483, 2018-08-03
March, 2021 FDA 483 Berman, Gary D., MD, Clinical Investigator - Form 483, 2021-03-29
October, 2018 FDA 483 Response Experimur, A Frontage Company - Form 483R, 2018-11-19
June, 2016 EIR Chhavi Chadha, MD - EIR, 2016-06-27
March, 2019 FDA 483 Response Animesh Pardanani - Form 483R, 2019-03-22
March, 2019 FDA 483 Animesh Pardanani - Form 483, 2019-03-08
February, 2020 FDA 483 Nassr, Ahmad, MD - Form 483, 2020-02-07
June, 2016 FDA 483 Response Chhavi Chadha, MD - Form 483R, 2016-07-13
October, 2018 FDA 483 Experimur, A Frontage Company - Form 483, 2018-10-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more